490 results
8-K
EX-99.2
AMED
Amedisys Inc.
24 Apr 24
Amedisys Reports First Quarter 2024 Financial Results
4:45pm
statements as defined by the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon current expectations
8-K
EX-99.1
AMED
Amedisys Inc.
24 Apr 24
Amedisys Reports First Quarter 2024 Financial Results
4:45pm
,” “will,” “could,” “would,” “should” and similar expressions are intended to identify forward-looking statements as defined by the Private Securities Litigation … to the proposed merger; the risk of litigation or regulatory action related to the proposed merger; changes in Medicare and other medical payment levels; changes
8-K
AMED
Amedisys Inc.
19 Mar 24
Regulation FD Disclosure
5:26pm
the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified
8-K
EX-99.2
5v6jk67onq d4lp0f
21 Feb 24
Amedisys Reports Fourth Quarter and Year-end 2023 Financial Results
4:30pm
8-K
EX-99.1
bw1j731km
21 Feb 24
Amedisys Reports Fourth Quarter and Year-end 2023 Financial Results
4:30pm
8-K
EX-99.2
qih5ff d7ml
24 Oct 23
Amedisys Reports Third Quarter 2023 Financial Results
4:31pm
8-K
EX-99.1
e0u1roryrv
24 Oct 23
Amedisys Reports Third Quarter 2023 Financial Results
4:31pm
8-K
k5buoa 46i
8 Sep 23
Submission of Matters to a Vote of Security Holders
4:57pm
DEFA14A
gsdp5 brcuepz
1 Sep 23
Additional proxy soliciting materials
5:14pm
8-K
gqj 3bv1amo
1 Sep 23
Other Events
5:11pm
DEFM14A
afhshxa9x6
10 Aug 23
Proxy related to merger
4:31pm
PREM14A
1p6 sjmi2
31 Jul 23
Preliminary proxy related to merger
5:05pm
8-K
EX-99.1
434xrdq0rze
26 Jul 23
Amedisys Reports Second Quarter 2023 Financial Results
4:30pm
8-K
EX-99.2
0i42v476vd6pcac
26 Jul 23
Amedisys Reports Second Quarter 2023 Financial Results
4:30pm
DEFA14A
reuoypt1l7yw bqoqs
26 Jun 23
Additional proxy soliciting materials
5:11pm